Aug 25, 2026 07:38AM
Aug 20, 2026 06:03AM
Aug 6, 2026 07:32AM
Jun 18, 2026 04:32PM
Jun 3, 2026 04:09PM
Jun 1, 2026 07:31AM
Jun 1, 2026 04:40AM Iovanace Biotherapeutics (IOVA) Reiterated at Market Outperform by Citizens
May 12, 2026 09:58AM
May 7, 2026 07:17AM
Apr 22, 2026 06:42AM
Apr 10, 2026 01:20PM
Feb 25, 2026 03:25AM
Feb 24, 2026 07:09AM
Feb 5, 2026 05:15PM Iovance reports 52% response rate for Amtagvi in early melanoma treatment
Dec 17, 2025 02:42PM
Nov 3, 2025 07:01AM
Aug 19, 2025 06:37AM
Aug 18, 2025 04:15PM
Aug 7, 2025 04:10PM
Jul 22, 2025 08:50AM
Jul 15, 2025 04:39AM Citizens JMP Reiterates Market Perform Rating on Iovanace Biotherapeutics (IOVA)
Jul 15, 2025 03:30AM
Jul 14, 2025 07:30AM
Jul 13, 2025 08:41AM
Jul 11, 2025 10:16AM
Jul 11, 2025 07:46AM
Jul 10, 2025 04:44PM
Jul 9, 2025 04:00PM IOVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Iovance Biotherapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Jul 9, 2025 03:46PM
Jul 9, 2025 01:35PM
Jul 8, 2025 03:36PM
Jul 7, 2025 08:15PM
Jul 7, 2025 09:16AM
Jul 7, 2025 07:33AM
Jul 6, 2025 10:30AM IOVA DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Iovance Biotherapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action
Jul 5, 2025 07:18AM
Jul 4, 2025 12:17PM
Jul 4, 2025 10:07AM
Jul 3, 2025 04:00PM
Jul 3, 2025 08:36AM
Jul 1, 2025 04:50PM
Jul 1, 2025 12:48PM IOVA Investors Have the Opportunity to Lead the Iovance Biotherapeutics Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
Jul 1, 2025 11:02AM
Jul 1, 2025 08:18AM
Jun 30, 2025 12:43PM
Jun 30, 2025 12:02PM
Jun 29, 2025 08:18AM
Jun 29, 2025 07:56AM
Jun 28, 2025 11:52AM IOVA FINAL DEADLINE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Iovance Biotherapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class
Jun 27, 2025 04:00PM

443,926 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All